Sat, Aug 30, 2014, 8:03 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • ilygod ilygod May 8, 2013 5:02 PM Flag

    Form 4 filed 3/7/13 shows acquisition at $9+ ASCO will not disappoint

    SYNTA PHARMACEUTICALS CORP: 4, Sub-Doc 1

    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Expires: December 31, 2014
    Estimated average burden
    hours per response 0.5

    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Vukovic Vojo
    (Last) (First) (Middle)
    C/O SYNTA PHARMACEUTICALS CORP., 45 HARTWELL AVENUE
    (Street)
    LEXINGTON MA 02421
    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    SYNTA PHARMACEUTICALS CORP [SNTA] 5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    SVP, Chief Medical Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    03/05/2013
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1.Title of Security
    (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
    (Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
    (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
    (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I)
    (Instr. 4) 7. Nature of Indirect Beneficial Ownership
    (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security
    (Instr. 3) 2.

 
SNTA
4.00-0.03(-0.74%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.